EAACI Congress 2025
BackTPS58 - Allergen immunotherapy 05
Sunday 15 Jun, 12:45 PM -
13:45 PM Glasgow, United Kingdom
Poster Zone
Thematic Poster Session
D3.169
Advantage of IgG reactivity testing for the analytical quantification of allergoids
D3.167
Allergoids: Characterising Identity Pre- and Post- Modification Using Compendial and Novel Methods
D3.174
Comparative analysis of extracts from Cupressus arizonica and Juniperus ashei pollens
D3.165
Consistent long term benefit of allergen immunotherapy in patients with allergic rhinitis
D3.170
Effectiveness and Safety Study of Subcutaneous Immunotherapy for Respiratory Allergy to Dermatophagoides and Lepidoglyphus Destructor
D3.173
Nationwide pivotal registry study on house dust mite immunotherapy in allergic rhinitis patients with or without asthma in China (NAVIGATOR)
D3.177
Potency of Dermatophagoides spp SLIT tablet compared to US standardized mite in ID testing
D3.164
Safety and Efficacy of VIT against Wasp Venom in Patients Older than 60 Years
D3.166
The mental health of adolescent patients with cat allergy improves with rapid dosing of depigmented cat allergoids
D3.176
The value of TNF and IL1RN genes in predicting the clinical efficacy of SCIT in children with asthma
D3.175
Tumor Necrosis Factor Receptor 2 (TNFR2) is crucial for the efficacy of Allergen-Specific Immunotherapy in a Pre-clinical Murine Model
D3.168
Validation of a novel serum-based basophil activation test (iBAT) to evaluate efficacy of a pivotal Phase III PQ Grass immunotherapy trial
D3.172
Аllergen-specific immunotherapy in patients with allergic rhinitis
